Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m

Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m

Submitted by admin on April 1, 2021 - 10:50am
Source: 
Pharmaceutical Business Review
News Tags: 
Takeda
OTC
M&A
Orifarm
Headline: 
Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
snippet: 

Takeda Pharmaceutical Company has completed the previously announced sale of a portfolio of select over-the-counter (OTC) pharma products and non-core assets to Orifarm Group for $670m.

Do Not Allow Advertisers to Use My Personal information